NDRA
ENDRA Life Sciences Inc.
NASDAQ · Healthcare · Medical - Diagnostics & Research · US
$4.81
−1.54%Next report
Analyst consensus
- Next report date
- Nov 13, 2026
- EPS estimate
- -$0.84
- Revenue estimate
- $100.0K
Latest reported
- Last report date
- Aug 14, 2026
- EPS actual
- -$0.63
- EPS estimate
- -$0.84
- Revenue actual
- —
- Revenue estimate
- $100.0K
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 7
- EPS misses (12Q)
- 5
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- -29.6%
- Revenue beats (12Q)
- —
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 14, 2026 | -$0.84 | -$0.63 | Beat 25.00% | — |
| May 18, 2026 | -$1.23 | -$1.09 | Beat 11.38% | — |
| Mar 31, 2026 | -$1.23 | -$3.26 | Miss -165.04% | — |
| Nov 14, 2025 | -$1.95 | -$1.75 | Beat 10.26% | — |
| Aug 14, 2025 | -$2.27 | -$1.71 | Beat 24.67% | — |
| May 15, 2025 | -$3.91 | -$2.59 | Beat 33.76% | — |
| Mar 31, 2025 | -$4.10 | -$9.40 | Miss -129.27% | $211.6K |
| Nov 15, 2024 | -$62 | -$5.85 | Beat 90.61% | — |
| Aug 14, 2024 | -$0.07 | -$140 | Miss -199700.00% | — |
| Nov 14, 2023 | -$0.43 | -$699 | Miss -162527.91% | — |
| Aug 14, 2023 | -$0.55 | -$752 | Miss -136581.82% | — |
| May 15, 2023 | -$1.8K | -$1.6K | Beat 8.82% | — |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 13, 2026